Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

9.34USD
16 Aug 2019
Change (% chg)

$0.27 (+2.98%)
Prev Close
$9.07
Open
$9.17
Day's High
$9.79
Day's Low
$9.17
Volume
146,552
Avg. Vol
145,172
52-wk High
$24.34
52-wk Low
$8.79

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Sean McCarthy

52 2018 Chairman of the Board, President, Chief Executive Officer

Lloyd Rowland

62 2018 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Nick Galli

2019 Senior Vice President, Chief Business Officer

W. Michael Kavanaugh

62 2015 Chief Scientific Officer and Head - Research and Non-Clinical Development

Rachel Humphrey

57 2015 Chief Medical Officer